Searchable abstracts of presentations at key conferences on calcified tissues

Bone Abstracts

Published by BioScientifica
Previous issue | Volume 5 | ECTS2016 | Next issue

43rd Annual European Calcified Tissue Society Congress

Rome, Italy
14 May 2016 - 17 May 2016

Card image cap

Poster Presentations

Osteoporosis: treatment

Previous section
Osteoporosis: pathophysiology and epidemiology
Table of contents
Next section
Other diseases of bone and mineral metabolism

ba0005p379 | Osteoporosis: treatment

Clinical features of atypical femur fracture

ba0005p380 | Osteoporosis: treatment

Postmenopausal osteoporosis tolerance and efficacy of different therapeutic protocols

ba0005p381 | Osteoporosis: treatment

Treatment outcomes during teriparatide use in Greece: country sub-analysis of the Exfos Observational Study

ba0005p382 | Osteoporosis: treatment

Effects of single bolus injection of vitamin D on serum FGF23, Sclerostin and DKK1 concentrations in vitamin D-deficient subjects

ba0005p383 | Osteoporosis: treatment

A interventional study in a real life setting to assess the clinical efficacy and effect to fracture in the 1 year after the injection of zoledronic acid in osteoporotic patients with long bone or spine, pelvic fractures

ba0005p384 | Osteoporosis: treatment

Magnesium together with Calsium and vitamin D improves the bone metabolism in (70y) healtly females

ba0005p385 | Osteoporosis: treatment

The effect of teriparatide on fracture healing of vertevral compression fracture in postmenopausal women

ba0005p386 | Osteoporosis: treatment

Atypical femoral fractures after long-term bisphosphonates therapy: case report

ba0005p387 | Osteoporosis: treatment

Effect of 61-week administration with beta-hydroxy-beta-methylbutyrate on volumetric bone mineral density of lumbar spine in osteoporotic patient

ba0005p388 | Osteoporosis: treatment

AMD3100 improves ovariectomy-induced osteoporosis in mice by facilitating mobilization of hematopoietic stem/progenitor cells

ba0005p389 | Osteoporosis: treatment

Hypercalcemia after discontinuation of long-term denosumab treatment

ba0005p390 | Osteoporosis: treatment

Denosumab therapy results in a high frequency of responders by bone mineral density in both treatment-naïve patients and patients switching therapies

ba0005p391 | Osteoporosis: treatment

Prevalence of osteoporosis and effectiveness of screening test using ultrasound bone densitometry and education in a community-dwelling population

ba0005p392 | Osteoporosis: treatment

The effect of oral dabigatran etexilate on bone density, strength, and microstructure in female and male mice

ba0005p393 | Osteoporosis: treatment

Long-term high-dose resveratrol supplementation reduces bone mass and strength in rats

ba0005p394 | Osteoporosis: treatment

Inhibitory effects of nanopartical calcium administration on dexamethasone-induced osteoporosis development in axial skeleton of pigs

ba0005p395 | Osteoporosis: treatment

Acute kidney injury after a single intravenous zoledronic acid administration in patients with osteoporosis

ba0005p396 | Osteoporosis: treatment

Oral health assessment necessary with comprehensive geriatric assessment

ba0005p397 | Osteoporosis: treatment

Evaluating dental health risk assessment amongst bisphosphonate users

ba0005p398 | Osteoporosis: treatment

Dementia and hip fractures-

ba0005p399 | Osteoporosis: treatment

Need for integrated proactive approach for dementia and hip fracture care

ba0005p400 | Osteoporosis: treatment

The upper two third of the reference interval of the serum calcium level is required for the optimal increase in lumbar bone mineral density by bisphosphonate and active vitamin D3 analogue for osteoporosis

ba0005p401 | Osteoporosis: treatment

Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK

ba0005p402 | Osteoporosis: treatment

Is recovery of lactation-induced bone loss influenced by immobilization in mice?

ba0005p403 | Osteoporosis: treatment

Biochemical monitoring of teriparatide efficacy in a real world setting

ba0005p404 | Osteoporosis: treatment

IV. zoledronic acid promotes healing of complicated stress fractures in the foot

ba0005p405 | Osteoporosis: treatment

Lithium chloride enhances bone formation and implant osseointegration in osteoporotic condition

ba0005p406 | Osteoporosis: treatment

Adherence and persistence to teriparatide treatment in patients attending a specialised Bone Health Service

ba0005p407 | Osteoporosis: treatment

Impact of 3-year vitamin D and calcium supplementation on mineral and organic matrix formation of trabecular bone in postmenopausal osteoporosis

ba0005p408 | Osteoporosis: treatment

Treat-to-target in osteoporosis. Mith or reality? Results of a Spanish Delphi study

ba0005p409 | Osteoporosis: treatment

Atypical femur fracture in an adolescent with X-linked osteoporosis based on PLS3 mutation

ba0005p410 | Osteoporosis: treatment

Can bone turnover markers help to define the duration of bisphosphonate drug holidays?

ba0005p411 | Osteoporosis: treatment

Establishment of a large sector-spanning fracture liaison service in Germany

ba0005p412 | Osteoporosis: treatment

The value of the central vertebral height restoration by kyphoplasty for treatment of biconcave vertebral compression fractures

ba0005p413 | Osteoporosis: treatment

Dose postoperative applications of diphosphonate medicine at an early stage have influence on union of fracture?

ba0005p414 | Osteoporosis: treatment

Teriparatide reduces the risk of vertebral fractures compared with standard care in patients with severe osteoporosis

ba0005p415 | Osteoporosis: treatment

rs72658163, a new heterozygous variant in COL1A2 associated with atypical femoral fracture

ba0005p416 | Osteoporosis: treatment

Hydrogen sulfide is a novel regulator of bone formation involved in the bone loss induced by estrogen deficiency

ba0005p417 | Osteoporosis: treatment

The fate of injected cement after percutaneous vertebroplasty

ba0005p418 | Osteoporosis: treatment

Globular adiponectin reverses trabecular osteopenia in ovariectomized rats

Published by BioScientifica

Bone Abstracts
ISSN 2052-1219 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more